Skip to content

A study comparing shoulder treatments (hydrodistension, nerve block, and their combination) to improve pain and movement in patients with frozen shoulder (stage II and III)

A Three-arm Randomized Control Trial Comparing Efficacy of Hydrodistension Hydrodistension With Suprascapular Nerve Block And Suprascapular Nerve Block Alone In Patients With Stage II and III (Hannafin And Chaia Staging) Adhesive Capsulitis - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2025/10/095568
Enrollment
54
Registered
2025-10-03
Start date
Unknown
Completion date
Unknown
Last updated
2025-10-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: M750- Adhesive capsulitis of shoulder

Interventions

Intervention1: Suprascapular nerve block: SSNB (suprascapular nerve block) is given at the spinoglenoid notch with 4 mL bupivacaine (0.5%), 4 mL lidocaine (2%), and 20 mg triamcinolone under ultrasoun

Sponsors

AIIMS
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: All adult patients who have given consent for the study and diagnosed to have primary Adhesive capsulitis based on Zuckerman`s criteria and are in Stage II & III (Hannafin and Chiaia classification) of Adhesive Capsulitis are included in the study. Zuckerman s diagnostic criteria, for diagnosis of adhesive capsulitis consist of: a) Sudden onset b) Range of motion (ROM) during the active and passive elevation of the shoulder less than 100 c) ROM limitation in external rotation less than 50 % on the contralateral side d) Shoulder pain during night e) Normal radiographical findings

Exclusion criteria

Exclusion criteria: 1)Patients who refuse the intervention. 2)who have a history of shoulder surgery. 3)breast surgery. 4)fracture around the shoulder and upper extremities. 5)have a cerebrovascular disease and cervical radiculopathy. 6)uncontrolled diabetes mellitus. 7) who underwent shoulder surgery during study. 8)any other shoulder pathology. 9)contraindicated for SSNB or allergic to local anaesthetic drugs.

Design outcomes

Primary

MeasureTime frame
Improvement in range of motionTimepoint: 2nd day, 2nd week, 4th week, 8th week, 12th week post intervention

Secondary

MeasureTime frame
Outcome of PainTimepoint: 2nd day, 2nd week, 4th week, 8th week, 12th week post intervention

Countries

India

Contacts

Public ContactAbdu Raheem KK

AIIMS Bibinagar

drranjithkumar@gmail.com9000536536

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026